Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2017-07-27 | 2017-09-08 | 17417 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-01-09 | 2018-01-19 | 35401 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
| LUTATHERA | 370MBq | SOLUTION | Resolved | 2022-05-06 | 2022-06-14 | 160113 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79076 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79079 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-25 | 2020-02-04 | 94696 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-30 | 2018-06-28 | 31273 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-10-24 | 55437 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-03-27 | 79064 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-13 | 79071 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-29 | 2019-08-12 | 82741 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-19 | 2020-01-15 | 101768 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-07 | 2020-03-03 | 102494 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-08 | 2020-11-07 | 123875 |
| LOPRESOR 50MG | 50MG | TABLET | Avoided shortage | 2017-11-02 | 2018-01-09 | 27902 |
| LOPRESOR 100MG | 100MG | TABLET | Resolved | 2017-05-29 | 2018-01-09 | 11438 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Resolved | 2021-10-28 | 2022-01-17 | 148460 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |